SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Price, Quote, News and Overview
NASDAQ:OMIC - Nasdaq - US82933R3084 - Common Stock - Currency: USD
OMIC Quote, Performance and Key Statistics
NASDAQ:OMIC (2/20/2025, 8:00:01 PM)
20.01
+0.05 (+0.25%)
The current stock price of OMIC is 20.01 USD. In the past month the price increased by 0.6%. In the past year, price increased by 21.27%.
OMIC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.56 | 161.38B | ||
| DHR | DANAHER CORP | 24.94 | 133.67B | ||
| A | AGILENT TECHNOLOGIES INC | 19.3 | 29.22B | ||
| IQV | IQVIA HOLDINGS INC | 12.92 | 25.37B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 24.42 | 20.94B | ||
| WAT | WATERS CORP | 27.04 | 19.10B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.91 | 14.60B | ||
| ICLR | ICON PLC | 9.95 | 11.50B | ||
| ILMN | ILLUMINA INC | 29.06 | 11.27B | ||
| RVTY | REVVITY INC | 18.74 | 11.03B | ||
| AVTR | AVANTOR INC | 15.1 | 10.29B | ||
| MEDP | MEDPACE HOLDINGS INC | 23.46 | 8.96B |
Related stock screener links
About OMIC
Company Profile
Singular Genomics Systems Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 255 full-time employees. The company went IPO on 2021-05-27. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The firm has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The firm is also engaged in developing PX, which is a development-stage multiomics platform.
Company Info
SINGULAR GENOMICS SYSTEMS IN
3010 Science Park Road
San Diego CALIFORNIA US
CEO: Andrew Spaventa
Employees: 255
Company Website: https://singulargenomics.com/
Investor Relations: https://investor.singulargenomics.com/
Phone: 18583337830
SINGULAR GENOMICS SYSTEMS IN / OMIC FAQ
What is the stock price of SINGULAR GENOMICS SYSTEMS IN today?
The current stock price of OMIC is 20.01 USD. The price increased by 0.25% in the last trading session.
What is the ticker symbol for SINGULAR GENOMICS SYSTEMS IN stock?
The exchange symbol of SINGULAR GENOMICS SYSTEMS IN is OMIC and it is listed on the Nasdaq exchange.
On which exchange is OMIC stock listed?
OMIC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SINGULAR GENOMICS SYSTEMS IN stock?
8 analysts have analysed OMIC and the average price target is 12.7 USD. This implies a price decrease of -36.54% is expected in the next year compared to the current price of 20.01. Check the SINGULAR GENOMICS SYSTEMS IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SINGULAR GENOMICS SYSTEMS IN worth?
SINGULAR GENOMICS SYSTEMS IN (OMIC) has a market capitalization of 50.63M USD. This makes OMIC a Micro Cap stock.
How many employees does SINGULAR GENOMICS SYSTEMS IN have?
SINGULAR GENOMICS SYSTEMS IN (OMIC) currently has 255 employees.
What are the support and resistance levels for SINGULAR GENOMICS SYSTEMS IN (OMIC) stock?
SINGULAR GENOMICS SYSTEMS IN (OMIC) has a support level at 19.94 and a resistance level at 20.02. Check the full technical report for a detailed analysis of OMIC support and resistance levels.
Is SINGULAR GENOMICS SYSTEMS IN (OMIC) expected to grow?
The Revenue of SINGULAR GENOMICS SYSTEMS IN (OMIC) is expected to grow by 9.93% in the next year. Check the estimates tab for more information on the OMIC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SINGULAR GENOMICS SYSTEMS IN (OMIC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OMIC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OMIC, evaluating the profitability, health, valuation and growth aspects
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Sales and EPS estimates to see what analysts future expectations are.
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Insider and Institutional Ownership to learn about the owners and their transactions.
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Chart to make your own analysis
- SINGULAR GENOMICS SYSTEMS IN (OMIC) Latest news and press-releases to stay up to date.
Does SINGULAR GENOMICS SYSTEMS IN (OMIC) stock pay dividends?
OMIC does not pay a dividend.
When does SINGULAR GENOMICS SYSTEMS IN (OMIC) report earnings?
SINGULAR GENOMICS SYSTEMS IN (OMIC) will report earnings on 2025-03-17, after the market close.
What is the Price/Earnings (PE) ratio of SINGULAR GENOMICS SYSTEMS IN (OMIC)?
SINGULAR GENOMICS SYSTEMS IN (OMIC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-35.09).
OMIC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to OMIC. When comparing the yearly performance of all stocks, OMIC is one of the better performing stocks in the market, outperforming 75.64% of all stocks.
OMIC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OMIC. OMIC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
OMIC Financial Highlights
Over the last trailing twelve months OMIC reported a non-GAAP Earnings per Share(EPS) of -35.09. The EPS increased by 8.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.27% | ||
| ROE | -70.04% | ||
| Debt/Equity | 0.04 |
OMIC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to OMIC. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 11.81% and a revenue growth 9.93% for OMIC